Diagnostic and prognostic role of cardiac pathology multicomplex autoimmune biological markers

Cover Page

Cite item


Relevance . Despite the large list of biological markers of cardiovascular diseases, not all have evidence-b ased effectiveness and independent prognostic value. Laboratory diagnostics of serum cardiospecific auto-antibodies for the diagnosis of myocyte cell damage has several potential advantages compared to the evaluation of traditional methods. These include the analysis of natural globulins to troponin I (cTnI), to alpha-a ctin 1 (ACTC1), to the heavy chain of beta-myosin 7B (MUN7B), which are based on a self-sustaining immune response to the myocardium’s own auto-antigens, which leads to damage to the cells expressing them. Purpose: To determine the diagnostic and practical value of quantitative indicators for the autoantibody complex to cardiomyocyte proteins to troponin I, to alpha-a ctin 1 and to the heavy chain of beta-myosin 7B in patients with cardiac pathology. Materials and Methods. The study of auto-antibodies to cTnI, ACTC1 and MUN7B in blood serum using laboratory enzyme immunoassay was carried out in patients with cardiac pathology undergoing inpatient treatment at the Regional Clinical Cardiology Dispensary in Stavropol. Additionally, an instrumental and laboratory examination was carried out in accordance with the clinical recommendations developed by the Association of Cardiovascular Surgeons, the Cardiological Society of Russia and approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. The work was examined and approved by the Ethics Committee of the North Caucasus Federal University. Results and Discussion . Changes in the level of autoantibodies to cTnI, ACTC1 and MUN7B proteins in blood serum were statistically significant (p < 0.01 v. s. p < 0.01). A persistent increase in the level of auto-antibodies to cTnI by 2.36 ng/ml (694.11 %), to ACTC1 by 3.6 ng/ml (141.73 %) and to MUN7B by 1.74 ng/ml (119.17 %) was found in individuals with confirmed cardiac pathology, when other criteria for laboratory analysis were within acceptable values, which determine their diagnostic and evidentiary effectiveness. Conclusion . The results of the study showed the relationship of changes in the activity of cardiospecific auto-A T to cardiomyocyte proteins (Anti-cTnI, Anti ACTC1, Anti-M YH7B) in patients with cardiac pathologies, indicating not only systemic membrane disorders (membranopathies), but also serve as convincing evidence of direct chemical changes in cardiomyocytes. A correlation has also been established between cardiomarkers of necrosis and ischemia and autoimmune globulins Anti-cTnI, Anti ACTC1, Anti-MYH7B, that confirms diagnostic and practical value of this laboratory analysis.

About the authors

Elvira D. Lovochkina

North Caucasus Federal University

Author for correspondence.
Email: Minaeva-Elvira1990@yandex.ru
ORCID iD: 0000-0002-1996-0920
Stavropol, Russian Federation


  1. Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nature Reviews Cardiology. 2016;13(6):368–78. doi: 10.1038/nrcardio.2016.25
  2. Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB; American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;26;133(4): e38–360. doi: 10.1161/CIR.0000000000000350
  3. Baldasseroni S, Opasich C, Gorini M, Lucci D, Marchionni N, Marini M, Campana C, Perini G, Deorsola A, Masotti G, Tavazzi L, Maggioni AP. Italian Network on Congestive Heart Failure Investigators. Left bundle-b ranch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure. Heart and Vessels. 2014;29:784–792.
  4. De Scheerder I, Vandekerckhove J, Robbrecht J, Algoed L, De Buyzere M, De Langhe J, De Schrijver G, Clement D. Antibodies aggravate the development of ischemic heart failure. Am J Cardiol. 1985;1:56(10):631–3. doi: 10.1016/0002-9149(85)91024-0
  5. Tobacman LS, Cammarato A. Cardiomyopathic troponin mutations predominantly occur at its interface with actin and tropomyosin. J Gen Physiol. 2021; 153(3): e202012815. doi: 10.1085/jgp.202012815
  6. Ryabkova VA. Churilov LP, Shubik YV. The role of autoantibodies against cardiomyocyte antigens in the development of cardiac arrhythmias and sudden cardiac death. Bulletin of Arrhythmology. 2019;26:4:21–31. (In Russian).
  7. Bilchenko OV. Troponin. Clinical significance and interpretation of laboratory test results. Emergency medicine. 2020;16(1):109–114. doi: 10.22141/2224-0586.16.1.2020.196938. (In Russian).
  8. Anderson L. Proteomics based on candidates in the search for biomarkers of cardiovascular diseases. Journal of Physiology. 2005;1:23–60. (In Russian).
  9. Chung EYM, Trinh K, Li J, Hahn SH, Endre ZH, Rogers NM, Alexander SI. Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics. Frontiers in Cardiovascular Medicine. 2022;20;9:868658. doi: 10.3389/fcvm.2022.868658
  10. Belyaev NG, Levochkina ED, Baturin VA, Rzhepakovsky IV, Abasova TV, Piskov SI. Auto-antibodies to cardiomyocyte proteins dynamics at different stages of simulated muscle loads. RUDN Journal of Medicine. 2022;26(1):51–61. doi: 10.22363/2313-0245-2022-261-51-61. (In Russian).
  11. Levochkina ED, Zherlitsina NA. The cardiovascular system of animals in conditions of adaptation to intense muscular loads. Biodiversity, Bioresources, issues of Biotechnology and public health in the North Caucasus region. 2021;190–194. (In Russian).
  12. Murakami U, Uchida K. Contents of myofibrillar proteins in cardiac, skeletal, and smooth muscles. J. Biochem. 2002;132(3):417–25 doi: 10.1093/oxfordjournals.jbchem.a135257
  13. Lyovochkina ED, Belyaev NG, Kotelnikova NY. Dynamics of hormonal status in men at risk of developing cardiovascular pathology. Collection of articles of the International scientific and Practical Conference. 2021:155–162. (In Russian).
  14. Stable ischemic heart disease. Clinical Recommendations 2020. Russian Journal of Cardiology. 2020;25(11):4076. doi: 10.15829/15604071-2020-4076. (In Russian).
  15. Ekedi NE, Axelrod AS, Shchekochikhin DY, Tebenkova EC, Zhelankin AV, Stonogina DA, Syrkina EA, Ternovoy S.K. Modern algorithm for the diagnosis of coronary heart disease: achievements and prospects. Cardiology and cardiovascular surgery. 2019;12(5): 418–428. doi: 10.17116/kardio201912051418. (In Russian).
  16. Zaichik AM, Poletaev AB, Churilov LP. Natural autoantibodies, immunological theories and preventive medicine. Bulletin of St. Petersburg University. Episode 11: Medicine. 2013;2:3–16. (In Russian).
  17. Levochkina ED, Belyaev NG, Baturin VA, Rzhepakovsky IV, Abasova TV, Smyshnov KM, Piskov SI. Prognostic value of autoantibodies to cardiomyocyte proteins in the diagnosis of chronic physical overexertion. RUDN Journal of Medicine. 2022;26(3):289–303. doi: 10.22363/2313-0245-2022-26-3-289-303. (In Russian).
  18. Karpenko YI. Myocardial fibrosis and arrhythmias: prediction of the effect of catheter ablation. Health of Kazakhstan. 2015;6(37):8–13. (In Russian).
  19. Yue Y, Castrichini M, Srivastava U, Fabris F, Shah K, Li Z, Qu Y, El- Sherif N, Zhou Z, January C, Hussain MM, Jiang XC, Sobie EA, Wahren-Herlenius M, Chahine M, Capecchi PL, Laghi- Pasini F, Lazzerini PE, Boutjdir M. Pathogenesis of the Novel Autoimmune- Associated Long-Q T Syndrome. Circulation. 2015;28;132(4):230–40. doi: 10.1161/CIRCULATIONAHA.115.009800
  20. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute heart diseases: present and future. Ya.M. Journal of the American College of Cardiology. 2006. P. 1–11. doi: 10.1016/j.jacc.2006.02.056
  21. Pinckard K, Baskin KK, Stanford KI. Effects of Exercise to Improve Cardiovascular Health. Front Cardiovasc Med. 2019:4;6:69. doi: 10.3389/fcvm.2019.00069

Copyright (c) 2023 Lovochkina E.D.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies